Tel :+86-755-86961139
Email :sales@vivo-light.com
English
linkedin instagram youtube
What Are You Looking For?
Multimodal OCT Imaging System Mobile OCT Imaging System Intravascular OCT Catheter Augmented Reality Vein Finder Mobile OCT Imaging Catheter Portable Vein Locator Device
Request A Quote
Leave A Message

Leave A Message

If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.
submit
banner

Milestone

Home About us

Milestone

Vivolight specializes in minimally invasive laser technology. Our R&D and manufacturing centers produce advanced devices like OCT imaging catheters and Vein Finders. Holding 140+ patents, we lead with groundbreaking innovations, ensuring precision and safety in healthcare solutions globally.

 

 

 

 

 

Vivolight history

  • Company Establishment

    2012

  • 1st projection vein finder developed and launched globally; 1st Intravascular OCT prototype developed in China

    2013

  • Animal study for 1st generation OCT system

    2016

  • Completion of OCT clinical trial

    2018

  • NMPA approval of P60 OCT system (1st generation)

    2020

  • NMPA approval of P80 OCT system (2nd generation, upgrade of P60 OCT system）

    2021

  • NMPA approval of Cornaris Mobile OCT system and of Imaging catheter LumenCross; Commencement of clinical trial for new indication of LumenCross

    2022

  • NMPA approval of Zero OCT system for Nero-intervention and Cornaris Integrated OCT (A high-end OCT system deeply integrated with DSA device in Cathlab)

    2024

  • First China-developed OCT manufacturer to obtain FDA clearance

    2025

2012

  • Company Establishment

2013

  • 1st projection vein finder developed and launched globally; 1st Intravascular OCT prototype developed in China

2016

  • Animal study for 1st generation OCT system

2018

  • Completion of OCT clinical trial

2020

  • NMPA approval of P60 OCT system (1st generation)

2021

  • NMPA approval of P80 OCT system (2nd generation, upgrade of P60 OCT system）

2022

  • NMPA approval of Cornaris Mobile OCT system and of Imaging catheter LumenCross; Commencement of clinical trial for new indication of LumenCross

2024

  • NMPA approval of Zero OCT system for Nero-intervention and Cornaris Integrated OCT (A high-end OCT system deeply integrated with DSA device in Cathlab)

2025

  • First China-developed OCT manufacturer to obtain FDA clearance

Leave A Message

Leave A Message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.
submit

Home

products

whatsApp

contact